Technology
Health
Biotechnology

AnaptysBio

$74.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.37 (1.87%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell AnaptysBio and other stocks, options, ETFs, and crypto commission-free!

About

AnaptysBio, Inc. Common Stock, also called AnaptysBio, is a clinical stage biotechnology company, which engages in developing antibody product candidates focused on unmet medical needs in inflammation. Read More Its pipeline includes ANB020, ANB019, and checkpoint receptor agonist antibodies. The company was founded by Andrew B. Cubitt, William J. Boyle and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.

Employees
78
Headquarters
San Diego, California
Founded
2005
Market Cap
2.02B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
324.33K
High Today
$75.54
Low Today
$73.43
Open Price
$73.83
Volume
69.47K
52 Week High
$110.00
52 Week Low
$54.26

Collections

Technology
Health
Biotechnology
Medical
2017 IPO
US
North America

News

The Motley FoolMay 8

AnaptysBio Started 2019 Quiet as a Ninja

28
Yahoo FinanceMay 1

Is AnaptysBio, Inc. (ANAB) A Good Stock To Buy?

The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the fourth quarter, which unveil their equity positions as of December 31. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund positions.

40
NasdaqMay 1

AnaptysBio to Present at the Bank of America Merrill Lynch Healthcare Conference

3

Earnings

-$0.92
-$0.71
-$0.51
-$0.30
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.